RTW Investments, LP 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:28 am Purchase |
2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 3,152,341 9.500% |
604,216 (+23.71%) |
Filing |
| 2023-02-14 10:09 am Purchase |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,548,125 9.600% |
534,524 (+26.55%) |
Filing |
| 2022-02-14 08:18 am Sale |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,013,601 9.700% |
-450,000 (-18.27%) |
Filing |
| 2021-02-12 09:42 am Unchanged |
2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,463,601 12.130% |
0 (Unchanged) |
Filing |
| 2020-10-26 2:16 pm Purchase |
2020-10-16 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW Investments, LP | 2,463,601 12.790% |
2,463,601 (New Position) |
Filing |